This site is intended for health professionals only
Friday 24 May 2019
Share |

Cancer drugs to be funded in Wales

Cancer patients in Wales, UK, have been granted greater access to life-prolonging treatment after four drugs were approved for funding on the NHS.

The ruling over Sutent, Avastin, Nexavar and Torisel was made while the National Institute for Health and Clinical Excellence (NICE) looks into prescription practices surrounding the drugs.

Wales's health minister, Edwina Hart, told NHS chiefs to provide the drugs to patients when appropriate until NICE makes its final decision on the drugs – expected to be in March.

Mrs Hart last month announced a review of funding requests for Sutent after concerns were raised about inconsistencies in prescribing the drug.

She said: "I think it is unacceptable for these patients to be kept waiting any longer and I am instructing local health boards to provide these drugs for kidney cancer to appropriate patients with immediate effect."

Funding decisions in Wales are down to the Welsh Assembly government and will not affect the outcome of the review, NICE announced.

Macmillan Cancer Support's general manager for Wales, Cath Lindley, welcomed the decision calling it "fantastic news" for kidney cancer patients in Wales.

Copyright Press Association 2009


Ads by Google

You are leaving

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?


Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.



Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher